Evidence map›Paper›PMID 30243413›Full record

ArticleJournal of substance abuse treatment2018

Access to treatment for alcohol use disorders following Oregon's health care reforms and Medicaid expansion.

Dennis McCarty, Yifan Gu, Stephanie Renfro, Robin Baker, Bonnie K Lind, K John McConnell

Abstract read
In one paragraph

Article in Journal of substance abuse treatment, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2020
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dennis McCartyOHSU - PSU School of Public Health, Oregon Health & Science University, Portland, OR, United States of America; Department of Psychiatry, Oregon Health & Science University, Portland, OR, United States of America. Electronic address: mccartyd@ohsu.edu.
Yifan GuCenter for Health Systems Effectiveness, Oregon Health & Science University, Portland, OR, United States of America.
Stephanie RenfroCenter for Health Systems Effectiveness, Oregon Health & Science University, Portland, OR, United States of America.
Robin BakerOHSU - PSU School of Public Health, Oregon Health & Science University, Portland, OR, United States of America.
Bonnie K LindCenter for Health Systems Effectiveness, Oregon Health & Science University, Portland, OR, United States of America; Department of Emergency Medicine, Oregon Health & Science University, Portland, OR, United States of America.
K John McConnellOHSU - PSU School of Public Health, Oregon Health & Science University, Portland, OR, United States of America; Center for Health Systems Effectiveness, Oregon Health & Science University, Portland, OR, United States of America; Department of Emergency Medicine, Oregon Health & Science University, Portland, OR, United States of America.

Funding

Western States Node of the National Drug Abuse Treatment Clinical Trials NetworkU10DA015815 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MCCARTY, DENNIS, SORENSEN, JAMES L · 2002 to 2015
$25.2M
Western States Node of the National Drug Abuse Treatment Clinical Trials Network (TMS for CUD) UG1DA015815 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Keith N. Humphreys, Philip Todd Korthuis · 2015 to 2026
$24.6M
Integrating Addiction Treatment and Medical Care in a Commercial Health PlanR01DA029716 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI MCCARTY, DENNIS · 2011 to 2015
$3.3M
Oregon's Coordinated Care Organizations Integrate Care for Drug Use DisordersR33DA035640 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI LIND, BONNIE · 2014 to 2017
$2.4M
Evaluating Coordinated Care OrganizationsR01MH100001 · NIMH · OREGON HEALTH & SCIENCE UNIVERSITY · PI LINDROOTH, RICHARD C., MCCONNELL, KENNETH JOHN · 2012 to 2015
$2.2M
Oregon's Coordinated Care Organizations Integrate Care for Drug Use DisordersR21DA035640 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI MCCARTY, DENNIS · 2013 to 2013
$219k
NIDA NIH HHS R01 DA029716NIDA NIH HHS R21 DA035640NIDA NIH HHS R33 DA035640NIDA NIH HHS U10 DA015815NIDA NIH HHS UG1 DA015815NIMH NIH HHS R01 MH100001
6 · The paper itself

Abstract

The study examines impacts of delivery system reforms and Medicaid expansion on treatment for alcohol use disorders within the Oregon Health Plan (Medicaid). Diagnoses, services and pharmacy claims related to alcohol use disorders were extracted from Medicaid encounter data. Logistic regression and interrupted time series analyses assessed the percent with alcohol use disorder entering care and the percent receiving pharmacotherapy before (January 2010-June 2012) and after (January 2013-June 2015) the initiation of Oregon's Coordinated Care Organization (CCO) model (July 2012-December 2012). Analyses also examined changes in access following Medicaid expansion (January 2014). Treatment entry rates increased from 35% in 2010 to 41% in 2015 following the introduction of CCOs and Medicaid expansion. The number of Medicaid enrollees with a diagnosed alcohol use disorder increased about 150% from 10,360 (2013) to 25,454 (2014) following Medicaid expansion. Individuals with an alcohol use disorder who were prescribed a medication to support recovery increased from 2.3% (2010) to 3.8% (2015). In Oregon, Medicaid expansion and health care reforms enhanced access and improved treatment initiation for alcohol use disorders.

Indexed as

Health Care ReformAdolescentAdultAlcoholismFemaleHealth Services AccessibilityHumansInterrupted Time Series AnalysisLogistic ModelsMaleMedicaidMiddle AgedOregonPractice Patterns, Physicians'United StatesYoung AdultAlcohol use disordersHealthcare reformsMedicaid expansionPharmacotherapy

Identifiers

PMID30243413
PMCPMC6205746

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.